News about Drug Discovery & Development

Merck Completes Acquisition of Cidara Therapeutics to Strengthen Influenza Pipeline

Merck, known as MSD outside the United States and Canada, has announced the successful completion of its cash tender offer, through a subsidiary, to acquire Cidara Therapeutics, Inc.

Drug Discovery & Development | 07/01/2026 | By Darshana |  278

Prokaryotics, Basilea Partner to Develop First-in-Class Broad-Spectrum Antifungal

Partnership between Prokaryotics and Basilea will develop broad-spectrum antifungal treatment that targets life-threatening invasive fungal infections.

Drug Discovery & Development | 07/01/2026 | By News Bureau |  152

Bayer Secures Breakthrough Status for Sevabertinib in HER2 NSCLC

US FDA and China’s CDE granted the designation for sevabertinib as a potential first-line therapy in advanced HER2-mutant non-small cell lung cancer.

Drug Discovery & Development | 07/01/2026 | By News Bureau |  334

China Approves Azstarys for ADHD Treatment

ArkBio secures NMPA nod for once-daily ADHD treatment in China.

Drug Discovery & Development | 06/01/2026 | By News Bureau |  506

Semaglutide Patent Expiry to Open Over USD 600 Million Opportunity for Generic Drugmakers

Industry estimates suggest that around 10 to 15 domestic and global drugmakers are likely to compete for this opportunity. In India, the introduction of generic semaglutide formulations, expected during the 2026–27 financial year, could generate incremental revenues of approximately USD 12–24 million within the branded formulations market.

Drug Discovery & Development | 06/01/2026 | By Darshana |  339

FDA Clears BrainSpace's Intellidrop for Automated, Closed-Loop Brain Fluid Management

BrainSpace, a medical technology company developing automated solutions for neurological injury, disease and degeneration, has received US Food and Drug Administration (FDA) 510(k) clearance for Intellidrop, its automated brain fluid management system.

Drug Discovery & Development | 05/01/2026 | By Darshana |  453

Elanco Secures USDA Approval for Befrena mAb, Strengthening Canine Dermatology Portfolio

Elanco Animal Health Incorporated has received approval from the US Department of Agriculture (USDA) for Befrena (tirnovetmab), marking the company’s entry into the fast-growing canine dermatology segment with an anti-IL-31 monoclonal antibody therapy for allergic and atopic dermatitis in dogs.

Drug Discovery & Development | 03/01/2026 | By Darshana |  348

CARsgen Advances Allogeneic CAR-T Manufacturing with Dual IND Filings

CARsgen Therapeutics Holdings Limited announced that it has submitted two separate Investigational New Drug (IND) applications to China’s National Medical Products Administration for its allogeneic BCMA-targeted CAR T-cell therapy, CT0596.

Drug Discovery & Development | 30/12/2025 | By Darshana |  126

Nona Biosciences Expands Discovery-to-Clinical Capabilities

Nona Biosciences has strengthened its integrated discovery-to-clinical framework by expanding proprietary platform technologies and enhancing preclinical and early clinical development capabilities, including CMC development, toxicology and clinical operations.

Drug Discovery & Development | 24/12/2025 | By News Bureau |  152

PM Narendra Modi Addresses Closing Ceremony of 2nd WHO Global Summit on Traditional Medicine

Addressing the closing ceremony of the Second WHO Global Summit on Traditional Medicine, Prime Minister Narendra Modi highlighted India’s leadership in traditional healthcare, the global impact of yoga and the establishment of key WHO institutions in Jamnagar and Delhi

Drug Discovery & Development | 20/12/2025 | By News Bureau |  162